Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-25-028783·REVIVA PHARMACEUTICALS HOLDINGS, INC.
Schedule 13D ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Common Stock, $0.0001 par value · CUSIP: 76152G100
Event date: 2025-12-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- VEDANTA PARTNERS, LLCReported CIK 0001502216
Shares: 5,367,069.00 · Class: 4.4%
- Parag SaxenaReported CIK 0001015823
Shares: 6,268,006.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-028783
- Form type
- SCHEDULE 13D/A
- Filer
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- CIK
- CIK 1742927
- Filed
- Dec 22, 2025
- Reporting period
- Dec 18, 2025
- Description
- Schedule 13D beneficial ownership